Losartan Potassium Tablet, Film Coated
Product Images NDC 63187-296

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 63187-296). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

63187-296-90 (Losartan50mg30s)

Losartan Potassium 50mg tablets are sold in a bottle of 30. The tablets are white to off-white, film-coated, and oval-shaped. The manufacturer is Hetero Labs Limited, with a product ID of RL029630. The tablets contain 50 mg of Losartan Potassium USP. They should be stored at a temperature between 20°C-25°C, and packaged in a bottle with the lot number of 00000. The tablets are prescription-only medication that should be kept out of children's reach. The scan provided is for Relabeled By Proficient Rx LP.*

FDA Label Image

Losartanaddress1 (Losartanaddress1)

FDA Label Image

Losartanaddress2 (Losartanaddress2)

FDA Label Image

Losartanfigure1 (Losartanfigure1)

FDA Label Image

Losartanfigure2 (Losartanfigure2)

This is a statistical or clinical study with a graph that shows the percentage of patients experiencing first-line or fatal stroke over time (measured in months). The study reports an adjusted risk reduction of 26% with a p-value of 0.001. No other information is available.*

FDA Label Image

Losartanfigure3 (Losartanfigure3)

This appears to be a table or figure of some sort, showing the number of events related to a composite primary endpoint broken down by demographic subgroups and different treatments. Without more context, it is not clear what the primary endpoint or treatments are for.*

FDA Label Image

Losartanfigure4 (Losartanfigure4)

The text is describing the percentage of patents with an event related to risk reduction, which is 18.1%. The unit of time for this percentage is not specified, but it is associated with the duration of several months. The text provided does not give enough information to determine what the unit of months refers to exactly.*

FDA Label Image

Losartanstructure (Losartanstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.